RET-Positive Metastatic NSCLC


 

Lecture Summary - ESMO 2022 on the Results of the Randomized DICIPLE Phase 3 Trial: Nivo + Ipi 6-Month Treatment vs. Continuation in Advanced NSCLC

6 views
September 15, 2022
0 Comments
Login to view comments. Click here to Login
RET-Positive Metastatic NSCLC